| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/30/1998 | US5773280 Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses |
| 06/30/1998 | US5773263 Production aflastatin A from streptomyces sp., a pharmaceutical composition and methods of use |
| 06/30/1998 | US5773231 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 06/30/1998 | US5773230 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 06/30/1998 | US5773209 Prevention of formation of oxidized polyunsaturated fatty acid, suppression of gene expression through redox sensitive pathways |
| 06/30/1998 | US5773032 Long-acting injection suspensions and a process for their preparation |
| 06/30/1998 | US5773026 Aqueous formulations of water-insoluble therapeutic agent comprising carotenoids and/or tocopherols |
| 06/30/1998 | US5773006 Lipsome containing IL-2 |
| 06/30/1998 | US5773001 Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
| 06/30/1998 | US5772997 Monoclonal antibodies directed to the HER2 receptor |
| 06/30/1998 | US5772995 Compositions and methods for enhanced tumor cell immunity in vivo |
| 06/30/1998 | US5772981 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 06/30/1998 | CA2227506A1 New ellipticine derivatives, their preparation process and the pharmaceutical compositions containing them |
| 06/27/1998 | CA2225906A1 3-deoxyglucosone production inhibitor |
| 06/25/1998 | WO1998027109A1 Cycloalkyl inhibitors of protein farnesyltransferase |
| 06/25/1998 | WO1998027108A2 New amide compounds and their use as nitric oxide synthase inhibitors |
| 06/25/1998 | WO1998027106A1 Aminosterol ester compounds |
| 06/25/1998 | WO1998027098A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
| 06/25/1998 | WO1998026801A1 Agent for identifying and treating metastasizing tumours |
| 06/25/1998 | WO1998026794A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 06/25/1998 | WO1998026791A1 The use of a cimicifuga racemosa extract |
| 06/25/1998 | WO1998022101A3 Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| 06/25/1998 | WO1998019649A3 Methods and compositions for inhibition of angiogenesis |
| 06/25/1998 | WO1998012220A3 Novel tumor proteins |
| 06/25/1998 | WO1998005769A3 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase |
| 06/25/1998 | DE19652815A1 Mittel zur Identifizierung und Therapie metastasierender Tumore Means for the identification and treatment of metastatic tumors |
| 06/25/1998 | CA2275213A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 06/25/1998 | CA2274779A1 Aminosterol ester compounds |
| 06/25/1998 | CA2264207A1 Cycloalkyl inhibitors of protein farnesyltransferase |
| 06/24/1998 | EP0848757A1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells |
| 06/24/1998 | EP0848720A2 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 06/24/1998 | EP0848613A1 Analogs for specific oligosaccharide-neuregulin interactions and uses thereof |
| 06/24/1998 | EP0848610A1 Use of a carbostyril derivative for inhibiting carcinogenesis |
| 06/24/1998 | EP0658117B1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
| 06/24/1998 | CN1185786A Sugar-modified cytostatics |
| 06/24/1998 | CN1185785A Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use |
| 06/24/1998 | CN1185742A Protein kinase c inhibitors |
| 06/24/1998 | CN1185738A Anticancer substance suppressing cancerous metastasis |
| 06/24/1998 | CN1185319A Tumor-blood-vessel growth inhibitor and medicinal composition |
| 06/24/1998 | CN1185292A Anti-cancer food composition capsule and preparation method thereof |
| 06/23/1998 | US5770687 Comformationally constrained backbone cyclized somatostatin analogs |
| 06/23/1998 | US5770624 Inhibitors of tumor necrosis factor alpha and matrix degrading metalloproteinease activity |
| 06/23/1998 | US5770619 Method of activating photosensitive agents |
| 06/23/1998 | US5770617 Terbenzimidazoles useful as antifungal agents |
| 06/23/1998 | US5770616 Pharmaceutical composition for inhibiting the growth of cancers |
| 06/23/1998 | US5770599 Quinazoline derivatives |
| 06/23/1998 | US5770598 Antitumor agents; reacting with carbonyl diimidazole and amidoximes |
| 06/23/1998 | US5770593 Method of determining a pharmaceutical combination preparations for use in anti-neoplastic therapy |
| 06/23/1998 | US5770581 Gene transcription and ionizing radiation: methods and compositions |
| 06/23/1998 | US5770455 Identifier tag which is a microchip that is pre-encoded or encodable with information that is related back to a detector when the tag is pulsed with electromagnetic radiation |
| 06/23/1998 | US5770430 Cellular injury response element and uses thereof |
| 06/23/1998 | US5770386 Methods and compositions for increasing the sensitivity of a cell to a DNA damaging agent |
| 06/23/1998 | US5770377 Detecting and preventing deactivation of tumor suppressors or anticarcinogenic agents |
| 06/23/1998 | US5770374 Methods for identifying oncogenes and anti-oncogenes |
| 06/23/1998 | US5770366 Melanoma-inhibiting protein |
| 06/23/1998 | US5770209 Acceleration of wound healing using connective tissue growth factor |
| 06/23/1998 | US5770197 Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules |
| 06/23/1998 | US5770195 Antitumor |
| 06/23/1998 | CA2086968C Quinazoline derivatives |
| 06/23/1998 | CA2038579C Utilization of enzymes |
| 06/23/1998 | CA1339924C 11beta-phenyl-14betha steroids |
| 06/20/1998 | CA2225273A1 Vitronectin receptor antagonists, their preparation and their use |
| 06/20/1998 | CA2225267A1 Vitronectin receptor antagonists, their preparation and their use |
| 06/18/1998 | WO1998026077A1 USE OF A VECTOR EXPRESSING DNA POLYMERASE β AS MEDICINE |
| 06/18/1998 | WO1998026068A1 Human apoptosis-related calcium-binding protein |
| 06/18/1998 | WO1998026067A1 Adipocyte-specific differentiation-related protein |
| 06/18/1998 | WO1998025971A1 Monovalent antibody fragments |
| 06/18/1998 | WO1998025956A2 Human gtp-binding proteins |
| 06/18/1998 | WO1998025946A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof |
| 06/18/1998 | WO1998025929A1 Epothilone analogs |
| 06/18/1998 | WO1998025899A1 Novel heterocyclically substituted benzamides and their use in fighting diseases |
| 06/18/1998 | WO1998025898A1 Seco precursors of cyclopropylindolines and their use as prodrugs |
| 06/18/1998 | WO1998025895A1 Inhibitors of the enzymatic activity of psa |
| 06/18/1998 | WO1998025883A1 Ketobenzamides as calpain inhibitors |
| 06/18/1998 | WO1998025875A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 06/18/1998 | WO1998025645A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene |
| 06/18/1998 | WO1998025642A2 Pharmaceutical formulations comprising a water-insoluble complex for sustained drug delivery |
| 06/18/1998 | WO1998025635A1 Submucosal tissue inhibition of neoplastic cell growth |
| 06/18/1998 | WO1998025634A1 Serum-derived factor inducing cell differentiation and medical uses thereof |
| 06/18/1998 | WO1998025627A1 17α-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT |
| 06/18/1998 | WO1998025626A1 Use of equilenin as an antioxidant |
| 06/18/1998 | WO1998025625A1 USE OF 17β-DIHYDROEQUILENIN AS AN ANTIOXIDANT |
| 06/18/1998 | WO1998025598A2 Methods and pharmaceutical compositions for inhibiting tumour cell growth |
| 06/18/1998 | WO1998013385A3 Non-naturally occurring lipoprotein particle |
| 06/18/1998 | CA2274958A1 Inhibitors of the enzymatic activity of psa |
| 06/18/1998 | CA2274847A1 Pharmaceutical formulations for sustained drug delivery |
| 06/18/1998 | CA2274838A1 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 06/18/1998 | CA2274837A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene |
| 06/18/1998 | CA2274833A1 Epothilone analogs |
| 06/18/1998 | CA2274739A1 Human apoptosis-related calcium-binding protein |
| 06/18/1998 | CA2274735A1 Human gtp-binding proteins |
| 06/18/1998 | CA2274728A1 Adipocyte-specific differentiation-related protein |
| 06/18/1998 | CA2273988A1 Novel heterocyclically substituted benzamides and their use in fighting diseases |
| 06/18/1998 | CA2272952A1 Seco precursors of cyclopropylindolines and their use as prodrugs |
| 06/18/1998 | CA2272089A1 17.alpha.-dihydroequilenin for use as a medical antioxidant |
| 06/18/1998 | CA2272087A1 Use of equilenin as an antioxidant |
| 06/18/1998 | CA2272074A1 Use of 17.beta.-dihydroequilenin as an antioxidant |
| 06/18/1998 | CA2269989A1 Submucosal tissue inhibition of neoplastic cell growth |
| 06/18/1998 | CA2245956A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof |
| 06/17/1998 | EP0848063A2 Nucleic acid constructs containing hybrid promotors for use in gene therapy |